Item 6. Selected Financial Data.

3K characters. Original on sec.gov · Markdown

Item 6. Selected Financial Data.



(in millions of dollars, except per share data)	2019			2018		2017		2016		2015
Net revenues	$	25,110		$	25,364	$	25,576	$	25,744	$	25,434
Net earnings (losses) (1)(2)(3)	(1,298		)	6,967		10,227		14,244		5,243
Net earnings (losses) attributable to Altria (1)(2)(3)	(1,293		)	6,963		10,222		14,239		5,241
Basic EPS — net earnings (losses) attributable to Altria (1)(2)(3)(4)	(0.70		)	3.69		5.31		7.28		2.67
Diluted EPS — net earnings (losses) attributable to Altria (1)(2)(3)(4)	(0.70		)	3.68		5.31		7.28		2.67
Dividends declared per share	3.28			3.00		2.54		2.35		2.17
Total assets (1)(3)(5)(6)	49,271			55,459		43,034		45,764		31,296
Long-term debt (5)	27,042			11,898		13,030		13,881		12,843
Total debt (5)	28,042			25,746		13,894		13,881		12,847

(1) Certain 2019 amounts include the impact of Altria’s impairment of its JUUL equity securities and the loss on Cronos-related financial instruments. For further discussion, see Note 7.

(2) Certain 2019, 2018 and 2017 amounts include the impact of the enactment of the Tax Reform Act. For further discussion, see Note 15. Income Taxes to the consolidated financial statements in Item 8 (“Note 15”).

(3) Certain 2016 amounts include the impact of the gain on the ABI/SABMiller business combination. For further discussion, see Note 7.

(4) “EPS” is defined as basic and diluted earnings (losses) per share.

(5) Certain 2019 and 2018 amounts include the impact of Altria’s investments in JUUL and Cronos. For further discussion, see Note 7, Note 9**.** Short-Term Borrowings and Borrowing Arrangements to the consolidated financial statements in Item 8 (“Note 9”) and Note 10. Long-Term Debt to the consolidated financial statements in Item 8 (“Note 10”).

(6) Certain immaterial prior year amounts have been adjusted to conform with the current year’s presentation.

The Selected Financial Data should be read in conjunction with Item 7 and Item 8.

Previous: Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. · Next: Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.